Causes of autism

Source: Wikipedia, the free encyclopedia.
This diagram shows the brain sections and how autism relates to them.

Many causes of

autism, including environmental and genetic factors, have been recognized or proposed, but understanding of the theory of causation of autism is incomplete.[1] Attempts have been made to incorporate the known genetic and environmental causes into a comprehensive causative framework.[2] ASD (autism spectrum disorder) is a neurodevelopmental disorder marked by impairments in communicative ability and social interaction, as well as restricted and repetitive behaviors, interests, or activities not suitable for the individual's developmental stage. The severity of symptoms and functional impairment vary between individuals.[3]

There are many known environmental, genetic, and biological causes of autism. Research indicates that genetic factors are predominate in the appearance of autism; however, the heritability of autism is complex, and many of the genetic interactions involved are unknown.[1] In rare cases, autism has been associated with agents that cause birth defects.[4] Many other causes have been proposed.

Different underlying brain dysfunctions have been hypothesized to result in the common symptoms of autism, just as completely different brain types result in intellectual disability.[1][5] In recent years, the prevalence and number of people diagnosed with the disorder have increased dramatically. There are many potential reasons for this occurrence, particularly the changes in the diagnostic criteria for autism.[6]

Environmental factors that have been claimed to contribute to autism or exacerbate its symptoms, or that may be important to consider in future research, include certain foods,

thimerosal causes autism, studies have indicated a possible link between thimerosal and autism in individuals with a hereditary predisposition for autoimmune disorders.[10][11] In 2007, the Center for Disease Control stated there was no support for a link between thimerosal and autism, citing evidence from several studies, as well as a continued increase in autism cases following the removal of thimerosal from childhood vaccines. [12]

Genetics

Genetic factors may be the most significant cause of autism. Early studies of twins had estimated heritability to be over 90%, meaning that genetics explains over 90% of whether a child will develop autism.[1] This may be an overestimation, as later twin studies estimate the heritability at between 60 and 90%.[1][13] Evidence so far still suggests a strong genetic component, with one of the largest and most recent studies estimating the heritability at 83%.[14] Many of the non-autistic co-twins had learning or social disabilities. For adult siblings the risk for having one or more features of the broader autism phenotype might be as high as 30%.[15]

In spite of the strong heritability, most cases of autism occur sporadically with no recent evidence of family history. It has been hypothesized that spontaneous de novo mutations in the sperm or egg contribute to the likelihood of developing autism.[16][1] There are two lines of evidence that support this hypothesis. First, individuals with autism have significantly reduced fecundity, they are 20 times less likely to have children than average, thus curtailing the persistence of mutations in ASD genes over multiple generations in a family.[1][5] Second, the likelihood of having a child develop autism increases with advancing parental age, and mutations in sperm gradually accumulate throughout a man's life.[1][17]

The first genes to be definitively shown to contribute to risk for autism were found in the early 1990s by researchers looking at gender-specific forms of autism caused by mutations on the X chromosome. An expansion of the CGG trinucleotide repeat in the

promoter of the gene FMR1 in boys causes fragile X syndrome, and at least 20% of boys with this mutation have behaviors consistent with autism spectrum disorder.[18][19] Mutations that inactivate the gene MECP2 cause Rett syndrome, which is associated with autistic behaviors in girls, and in boys the mutation is embryonic lethal.[20]

Besides these early examples, the role of de novo mutations in autism first became evident when

megabases. Microarray analysis has shown that de novo CNVs occur at a significantly higher rate in sporadic cases of autism as compared to the rate in their typically developing siblings and unrelated controls. A series of studies have shown that gene disrupting de novo CNVs occur approximately four times more frequently in autism than in controls and contribute to approximately 5–10% of cases.[16][23][24][25] Based on these studies, there are predicted to be 130–234 autism-related CNV loci.[25] The first whole genome sequencing study to comprehensively catalog de novo structural variation at a much higher resolution than DNA microarray studies has shown that the mutation rate is approximately 20% and not elevated in autism compared to sibling controls.[26] However, structural variants in individuals with autism are much larger and four times more likely to disrupt genes, mirroring findings from CNV studies.[26]

CNV studies were closely followed by exome sequencing studies, which sequence the 1–2% of the genome that codes for proteins (the "exome"). These studies found that de novo gene inactivating mutations were observed in approximately 20% of individuals with autism, compared to 10% of unaffected siblings, suggesting the etiology of autism is driven by these mutations in around 10% of cases.[27][28][29][30][31][32] There are predicted to be 350-450 genes that significantly increase susceptibility to autism when impacted by inactivating de novo mutations.[33] A further 12% of cases are predicted to be caused by protein altering missense mutations that change an amino acid but do not inactivate a gene.[29] Therefore, approximately 30% of individuals with autism have a spontaneous de novo large CNV that deletes or duplicates genes, or mutation that changes the amino acid code of an individual gene. A further 5–10% of cases have inherited structural variation at loci known to be associated with autism, and these known structural variants may arise de novo in the parents of affected children.[26]

Tens of genes and CNVs have been definitively identified based on the observation of recurrent mutations in different individuals, and suggestive evidence has been found for over 100 others.[34] The Simons Foundation Autism Research Initiative (SFARI) details the evidence for each genetic locus associated with autism.[35]

These early gene and CNV findings have shown that the cognitive and behavioral features associated with each of the underlying mutations is variable. Each mutation is itself associated with a variety of clinical diagnoses, and can also be found in a small percentage of individuals with no clinical diagnosis.[36][37] Thus the genetic disorders that comprise autism are not autism-specific. The mutations themselves are characterized by considerable variability in clinical outcome and typically only a subset of mutation carriers meet criteria for autism. This variable expressivity results in different individuals with the same mutation varying considerably in the severity of their observed particular trait.[38]

The conclusion of these recent studies of de novo mutation is that the spectrum of autism is breaking up into quanta of individual disorders defined by genetics.[38]

One gene that has been linked to autism is SHANK2.[39] Mutations in this gene act in a dominant fashion. Mutations in this gene appear to cause hyperconnectivity between the neurons.

A study conducted on 42,607 autism cases has identified 60 new genes, five of which had a more moderate impact on autistic symptoms. The related gene variants were often inherited from the participant's parents.[40]

Metabolic disorders

Selected metabolic conditions which may (rarely) be associated with an ASD appearance are:[41]

Disorders of amino acid metabolism

Disorders of γ-aminobutyric acid metabolism

Disorders of cholesterol metabolism

  • Smith-Lemli-Opitz syndrome

Disorders associated with cerebral folate deficiency

Disorders of creatine transport or metabolism

Disorders of carnitine biosynthesis

  • 6-N-trimethyllysine dioxygenase deficiency

Disorders of purine and pyrimidine metabolism

Lysosomal storage disorders

Mitochondrial disorders

Others

Epigenetics